Multiple sclerosis: Improve monitoring, inform treatment decisions

When it comes to clinical research, the whole is more than the sum of its parts.
Doris Pischitz
Published on April 21, 2022

Research into multiple sclerosis (MS) is no exception. Ten leading clinical centers, the biotechnology company Biogen, and Siemens Healthineers have joined forces to help combat this disease of the central nervous system.

Multiple sclerosis: Doctor talking to a patient

Digging into real-world data

Multiple sclerosis: Patient undergoing a head MRI exam

The role of imaging

Precision diagnostics, precision treatment

By Doris Pischitz
Doris Pischitz is an editor in corporate communications at Siemens Healthineers. The team specializes in topics related to healthcare, medical technology, disease areas, and digitalization.